The panel discusses the evolution of the "renal diet," emerging evidence on phosphorus bioavailability, the impact of food additives and processing, and how individualized nutrition counseling can improve patient outcomes. They also review traditional phosphorus binders, challenges with adherence and pill burden, and the emerging role of tenapanor, a first-in-class phosphorus blocker. Listeners will gain practical insights for helping patients navigate phosphorus management while maintaining a balanced, patient-centered approach to nutrition and quality of life.

This episode is supported by Ardelyx.

Please click here, to view a clinical bulletin update on managing hyperphosphatemia in patients on dialysis.

Upon completion of the podcast, please complete this short survey: https://nkf.jotform.com/261544521599868